Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anaptysbio Inc (ANAB)

Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anaptysbio Inc 10770 WATERIDGE CIRCLE SUITE 210 SAN DIEGO CA 92121 USA

www.anaptysbio.com Employees: 104 P: 858-362-6295

Sector:

Medical

Description:

AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 1,879,831
Enterprise Value, $K 1,641,631
Shares Outstanding, K 28,748
Float, K 19,117
% Float 66.50%
Short Interest, K 5,366
Short Float 18.67%
Days to Cover 17.99
Short Volume Ratio 0.64
% of Insider Shareholders 33.50%

Financials:

Annual Sales, $ 234,600 K
Annual Net Income, $ -13,230 K
Last Quarter Sales, $ 108,250 K
Last Quarter Net Income, $ 49,610 K
EBIT, $ 47,890 K
EBITDA, $ 45,580 K

Growth:

1-Year Return 257.28%
3-Year Return 198.67%
5-Year Return 198.26%
5-Year Revenue Growth 212.80%
5-Year Earnings Growth 36.99%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.58 on 03/03/26
Next Earnings Date 05/04/26
Earnings Per Share ttm -0.52
EPS Growth vs. Prev Qtr 203.85%
EPS Growth vs. Prev Year 319.44%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ANAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,101.24%
Return-on-Assets % -3.59%
Profit Margin % -5.64%
Debt/Equity 0.00
Price/Sales 7.72
Price/Cash Flow N/A
Price/Book 46.89
Book Value/Share 1.34
Interest Coverage -0.84
60-Month Beta 0.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.